Influence of diabetes mellitus on mortality in breast cancer patients

ANZ Journal of Surgery

Volumn 85, Issue 12, 2015, Pages 972-978

  Zhou, Yunhai ^a   Zhang, Xiang ^a   Gu, Chen ^a   Xia, Jiazeng ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Breast cancer; Diabetes mellitus; Diagnosis; Mortality

Indexed keywords

ADULT; AGED; BREAST TUMOR; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; FEMALE; HUMAN; META ANALYSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; FEMALE; HUMANS; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 85000103864     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12877     Document Type: Article

References (38)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2010 incidence and mortality web-based report. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA, USA, 2013.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69-90.
3. American Cancer Society. Breast cancer facts and figures 2007-2008. American Cancer Society, Atlanta, 2008.
4. Peairs KS, Barone BB, Snyder CF etal. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J. Clin. Oncol. 2011; 29: 40-46.
5. Giovannucci E, Harlan DM, Archer MC etal. Diabetes and cancer: a consensus report. CA Cancer J. Clin. 2010; 60: 207-221.
6. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res. Treat. 2006; 98: 349-356.
7. Barone BB, Yeh HC, Snyder CF etal. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008; 300: 2754-2764.
8. Kaplan MA, Pekkolay Z, Kucukoner M etal. Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med. Oncol. 2012; 29: 1576-1580.
9. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010; 25: 603-605.
10. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285: 885-892.
11. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol. 2004; 159: 1160-1167.
12. Du W, Simon MS. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res. Treat. 2005; 91: 243-248.
13. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
14. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005; 294: 1765-1772.
15. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int. J. Cancer 2007; 120: 1986-1992.
16. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res. Treat. 2008; 109: 389-395.
17. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J. Clin. Oncol. 2009; 27: 2170-2176.
18. Zhou XH, Qiao Q, Zethelius B etal. Diabetes, prediabetes and cancer mortality. Diabetologia 2010; 53: 1867-1876.
19. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S etal. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 2011; 364: 829-841.
20. Irwin ML, Duggan C, Wang CY. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J. Clin. Oncol. 2011; 29: 47-53.
21. Lam EK, Batty GD, Huxley RR etal. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann. Oncol. 2011; 22: 730-738.
22. Schrauder MG, Fasching PA, Häberle L etal. Diabetes and prognosis in a breast cancer cohort. J. Cancer Res. Clin. Oncol. 2011; 137: 975-983.
23. Chen WW, Shao YY, Shau WY etal. The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist 2012; 17: 485-491.
24. Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control 2012; 23: 1193-1203.
25. Griffiths RI, Danese MD, Gleeson ML, Valderas JM. Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. BMC Cancer 2012; 12: 613.
26. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K. The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer 2012; 118: 1353-1361.
27. Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, Martin RM. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control 2012; 23: 1785-1795.
28. Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 2012; 35: 113-118.
29. Nechuta S, Lu W, Zheng Y etal. Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res. Treat. 2013; 139: 227-235.
30. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463.
31. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer 2007; 121: 856-862.
32. García-Jiménez C, García-Martínez JM, Chocarro-Calvo A, De la Vieja A. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose. J. Mol. Endocrinol. 2014; 52: R51-66.
33. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 2012; 23: 967-981.
34. Alvino CL, Ong SC, McNeil KA etal. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II. PLoS ONE 2011; 6: e27488.
35. Fleming HE, Janzen V, Lo Celso C etal. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008; 2: 274-283.
36. Allen NE, Key TJ, Dossus L etal. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer 2008; 15: 485-497.
37. Chocarro-Calvo A, García-Martínez JM, Ardila-González S, De la Vieja A, García-Jiménez C. Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. Mol. Cell 2013; 49: 474-486.
38. Brasky TM, Potter JD, Kristal AR etal. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control 2012; 23: 431-444.